NCT/Study#
NCT06730750 /
BMS-CA238-0001
A Phase 1/2a, Multicenter, Open-label Study of BMS-986490 with or without Bevacizumab in Advanced Solid Tumors
DISEASE GROUP:
Advanced Solid Tumors
current phase:
Phase I/II
STUDY STATUS:
Enrolling
Location:
Hackensack, NJ
For More information:
